SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 10-Q

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2020

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number 001-36245
RiceBran Technologies
(Exact Name of Registrant as Specified in its Charter)

California
(State or other jurisdiction of
incorporation or organization)
 
87-0673375
(I.R.S. Employer Identification No.)
1330 Lake Robbins Drive, Suite 250
The Woodlands, TX
 (Address of Principal Executive Offices)
 
77380
(Zip Code)

(281) 675-2421
(Registrant’s telephone number, including area code)
 
None
(Former name, former address and former fiscal year, if changed since last report

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☒  No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company, or an emerging company.  See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐
Accelerated filer ☐
Non-accelerated filer ☒
Smaller reporting company ☒
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule l2b-2 of the Exchange Act).  Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
 
Trading symbol
 
Name of each exchange on which registered
Common Stock, no par value per share
 
RIBT
 
The NASDAQ Capital Market

As of April 27, 2020, shares of the registrant’s common stock outstanding totaled 40,097,517



RiceBran Technologies
Index
Form 10-Q

PART I. FINANCIAL INFORMATION
Page
 
Item 1.
3
    3
    4
    5
     6
 
Item 2.
15
 
Item 3.
16
 
Item 4.
17
PART II. OTHER INFORMATION
 
 
Item 1.
17
 
Item 1A.
17
 
Item 2.
17
 
Item 3.
17
 
Item 4.
17
 
Item 5.
17
 
Item 6.
17
19

Cautionary Note about Forward-Looking Statements

This quarterly report on Form 10-Q contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.  All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue, liquidity or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services, products or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing.  Forward-looking statements may include the words “may,” “could,” “will,” “estimate,” “intend,” “continue,” “believe,” “expect” or “anticipate” or other similar words.  The forward-looking statements contained herein reflect our current views with respect to future events and are subject to certain risks, uncertainties and assumptions.  Actual results may differ materially from those projected in such forward-looking statements due to a number of factors, risks and uncertainties, including the factors that may affect future results set forth in this Current Report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2019.  We disclaim any obligation to update any forward looking statements as a result of developments occurring after the date of this quarterly report.

Unless the context requires otherwise, references to “we,” “us,” “our” and “the Company” refer to RiceBran Technologies and its consolidated subsidiaries.

PART I. FINANCIAL INFORMATION

Item 1.
Financial Statements.

RiceBran Technologies
Condensed Consolidated Statements of Operations
Three Months Ended March 31, 2020 and 2019
(Unaudited) (in thousands, except share and per share amounts)

   
Three Months Ended
 
   
2020
   
2019
 
             
Revenues
 
$
8,330
   
$
6,364
 
Cost of goods sold
   
8,735
     
6,021
 
Gross profit (loss)
   
(405
)
   
343
 
Selling, general and administrative expenses
   
2,550
     
3,341
 
Operating loss
   
(2,955
)
   
(2,998
)
Interest income
   
11
     
-
 
Interest expense
   
(49
)
   
(12
)
Other expense
   
(45
)
   
(1
)
Other income
   
5
     
-
 
Loss before income taxes
   
(3,033
)
   
(3,011
)
Income tax benefit
   
-
     
-
 
Loss from continuing operations
   
(3,033
)
   
(3,011
)
Loss from discontinued operations
   
-
     
(216
)
Net loss
 
$
(3,033
)
 
$
(3,227
)
                 
Basic loss per common share:
               
Continuing operations
 
$
(0.08
)
 
$
(0.10
)
Discontinued operations
   
-
     
(0.01
)
Basic loss per common share
 
$
(0.08
)
 
$
(0.11
)
                 
Diluted loss per common share:
               
Continuing operations
 
$
(0.08
)
 
$
(0.10
)
Discontinued operations
   
-
     
(0.01
)
Diluted loss per common share
 
$
(0.08
)
 
$
(0.11
)
                 
Weighted average number of shares outstanding:
               
Basic
   
39,963,155
     
29,347,318
 
Diluted
   
39,963,155
     
29,347,318
 

See Notes to Unaudited Condensed Consolidated Financial Statements

RiceBran Technologies
Condensed Consolidated Balance Sheets
(Unaudited) (in thousands, except share amounts)

   
March 31,
2020
   
December 31,
2019
 
ASSETS
           
Current assets:
           
Cash and cash equivalents
 
$
5,517
   
$
8,444
 
Accounts receivable, net of allowance for doubtful accounts of $50 and $347
   
5,106
     
3,738
 
Inventories
   
1,916
     
898
 
Other current assets
   
894
     
691
 
Total current assets
   
13,433
     
13,771
 
Property and equipment, net
   
18,769
     
19,077
 
Operating lease right-of-use assets
   
2,678
     
2,752
 
Goodwill
   
3,915
     
3,915
 
Intangible assets
   
890
     
950
 
Other long-term assets
   
-
     
27
 
Total assets
 
$
39,685
   
$
40,492
 
                 
LIABILITIES AND SHAREHOLDERS' EQUITY
               
Current liabilities:
               
Accounts payable
 
$
1,146
   
$
833
 
Commodities payable
   
1,937
     
829
 
Accrued salary, wages and benefits
   
1,051
     
877
 
Accrued expenses
   
690
     
884
 
Customer prepayments
   
-
     
12
 
Operating lease liabilities, current portion
   
316
     
309
 
Due under insurance premium finance agreements
   
314
     
116
 
Finance lease liabilities, current portion
   
102
     
101
 
Due under factoring agreement
   
2,306
     
1,823
 
Long-term debt, current portion
   
29
     
28
 
Total current liabilities
   
7,891
     
5,812
 
Operating lease liabilities, less current portion
   
2,543
     
2,674
 
Finance lease liabilities, less current portion
   
164
     
190
 
Long-term debt, less current portion
   
65
     
73
 
Total liabilities
   
10,663
     
8,749
 
Commitments and contingencies
               
Shareholders' equity:
               
Preferred stock, 20,000,000 shares authorized: Series G, convertible, 3,000 shares authorized, stated value $225, 225 shares, issued and outstanding
   
112
     
112
 
Common stock, no par value, 50,000,000 shares authorized, 40,092,197 shares and 40,074,483 shares, issued and outstanding
   
319,123
     
318,811
 
Accumulated deficit
   
(290,213
)
   
(287,180
)
Total shareholders' equity
   
29,022
     
31,743
 
Total liabilities and shareholders' equity
 
$
39,685
   
$
40,492
 

See Notes to Unaudited Condensed Consolidated Financial Statements

RiceBran Technologies
Condensed Consolidated Statements of Cash Flows
Three Months Ended March 31, 2020 and 2019
(Unaudited) (in thousands)

   
Three Months Ended
 
   
2020
   
2019
 
Cash flow from operating activities:
           
Net loss
 
$
(3,033
)
 
$
(3,227
)
Loss from discontinued operations
   
-
     
216
 
Loss from continuing operations
   
(3,033
)
   
(3,011
)
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities
               
Depreciation
   
579
     
408
 
Amortization
   
59
     
2
 
Stock and share-based compensation
   
312
     
392
 
Other
   
(79
)
   
(48
)
Changes in operating assets and liabilities, net of impact of acquisitions:
               
Accounts receivable
   
(1,315
)
   
(1,244
)
Inventories
   
(1,018
)
   
(149
)
Accounts payable and accrued expenses
   
231
     
(294
)
Commodities payable
   
1,108
     
(1,818
)
Other
   
(178
)
   
(359
)
Net cash used in operating activities
   
(3,334
)
   
(6,121
)
Cash flows from investing activities:
               
Purchases of property and equipment
   
(221
)
   
(1,160
)
Net cash used in investing activities
   
(221
)
   
(1,160
)
Cash flows from financing activities:
               
Payments on factoring agreement
   
(6,995
)
   
-
 
Advances on factoring agreement
   
7,455
     
-
 
Advances on insurance premium finance agreements
   
344
     
272
 
Payments on insurance premium finance agreements
   
(144
)
   
(112
)
Payments of debt and finance lease liabilities
   
(32
)
   
(278
)
Proceeds from issuance of common stock and pre-funded warrant, net of issuance costs
   
-
     
11,593
 
Proceeds from common stock warrant exercises
   
-
     
1,980
 
Proceeds from common stock option exercises
   
-
     
60
 
Net cash provided by financing activities
   
628
     
13,515
 
Net change in cash and cash equivalents and restricted cash
 
$
(2,927
)
 
$
6,234
 
                 
Cash and cash equivalents and restricted cash, beginning of period
               
Cash and cash equivalents
 
$
8,444
   
$
7,044
 
Restricted cash
   
-
     
225
 
Cash and cash equivalents and restricted cash, beginning of period
   
8,444
     
7,269
 
Cash and cash equivalents and restricted cash, end of period
               
Cash and cash equivalents
   
5,517
     
13,278
 
Restricted cash
   
-
     
225
 
Cash and cash equivalents and restricted cash, end of period
   
5,517
     
13,503
 
Net change in cash and cash equivalents and restricted cash
 
$
(2,927
)
 
$
6,234
 
                 
Supplemental disclosures:
               
Cash paid for interest
 
$
26
   
$
12
 
Cash paid for income taxes
 
$
-
   
$
-
 

See Notes to Unaudited Condensed Consolidated Financial Statements

RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

NOTE 1. BASIS OF PRESENTATION

In the opinion of management, the accompanying unaudited condensed consolidated financial statements (interim financial statements) of RiceBran Technologies and its subsidiaries were prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and the rules and regulations of the Securities and Exchange Commission (SEC) for reporting on Form 10-Q; therefore, they do not include all of the information and notes required by GAAP for complete financial statements.  The interim financial statements contain all adjustments necessary to present fairly the interim results of operations, financial position and cash flows for the periods presented of a normal and recurring nature necessary to present fairly the interim results of operations, financial position and cash flows for the periods presented.

These interim financial statements should be read in conjunction with the consolidated audited financial statements and notes thereto in our Annual Report on Form 10-K for the year ended December 31, 2019, which included all disclosures required by generally accepted accounting principles.

The results reported in these interim financial statements are not necessarily indicative of the results to be expected for the full fiscal year, or any other future period, and have been prepared based on the realization of assets and the satisfaction of liabilities in the normal course of business.

NOTE 2. BUSINESS

We are a specialty ingredient company focused on producing value-added processing and marketing of healthy, natural and nutrient dense products derived from rice and other small grains, and the by-products created in the milling of these grains. Notably, we apply our proprietary technologies to convert raw rice bran into stabilized rice bran (SRB), and high value derivative products including: RiBalance, a rice bran nutritional package derived from SRB; RiSolubles, a nutritious, carbohydrate and lipid rich fraction of RiBalance; RiFiber, a fiber rich insoluble derivative of RiBalance and ProRyza, a rice bran protein-based product; and a variety of other valuable derivatives extracted from these core products.

In granular form, SRB is a food additive used in the production of products for both human and animal consumption. We believe SRB has certain inherent qualities that make it more attractive for this purpose than food additives based on the by-products of other agricultural commodities, such as corn and soybeans.  Our SRB and refined SRB products and derivatives support the production of healthy, natural, hypoallergenic, gluten free, and non-genetically modified ingredients and supplements for use in meats, baked goods, cereals, coatings, health foods, and high-end animal nutrition.  Our target customers are natural food, food and animal nutrition manufacturers, wholesalers and retailers, both domestically and internationally.

We manufacture and distribute SRB in various granulations from four locations: two leased facilities located within supplier-owned rice mills in Arbuckle and West Sacramento, California; one company-owned facility in Mermentau, Louisiana; and our company-owned rice mill in Wynne, Arkansas.  At our Dillon, Montana facility, we produce SRB based products and derivatives that have been further refined through our proprietary processes.  Our rice mill in Wynne, Arkansas also supplies grades U.S. No. 1 and No. 2 premium long and medium white rice.  In April 2019, we purchased a grain processing facility in East Grand Forks, Minnesota, to expand the variety of grains which we can offer to the market.

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Recent Accounting Guidance

Recent accounting standards not yet adopted

The following discusses the accounting standard(s) not yet adopted that will, or are expected to, result in a significant change in practice and/or have a significant financial impact on us.

RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

In June 2016, the Financial Accounting Standards Board (FASB) issued guidance ASU No. 2016-13 Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments which changes the accounting for credit losses for certain instruments, including trade receivables, from an incurred loss method to a current expected loss method.  The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts.  The guidance, and subsequent guidance related to the topic, is effective for our annual and interim periods beginning in 2023, and must be adopted on a modified retrospective approach through cumulative-effect adjustment to retained earnings as of January 1, 2023.  Based on the nature of our current receivables and our credit loss history, we do not expect the adoption of the guidance to have a significant impact on our results of operations, financial position, or cash flows.
Recently adopted accounting standards

In December 2019, the FASB issued guidance ASU No. 2019-12 - Income Taxes (Topic 740: Simplifying the Accounting for Income Taxes which, among other things, removed an exception in the guidance to the incremental approach for intraperiod tax allocation when there is a loss from continuing operations and income or a gain from other items such as discontinued operations.  We early adopted the guidance effective January 1, 2020.  Adoption of the guidance had no impact on our results of operations, financial position, or cash flows.

Reclassifications – Certain reclassifications have been made to amounts reported for the prior period to achieve consistent presentation with the current period. Such reclassifications had no impact on previously reported net loss or shareholders’ equity.

NOTE 4. ACQUISITION

On April 4, 2019, we acquired substantially all of the assets comprising the business of MGI Grain Processing, LLC, a Minnesota limited liability company, now conducting business as MGI Grain Incorporated (MGI). The results of MGI’s operations are included in our consolidated financial statements beginning April 4, 2019.  The following table provides unaudited pro forma information for the three months ended March 31, 2019, as if the MGI acquisition had occurred January 1, 2019.

Revenues (in thousands)
 
$
7,506
 
Loss from continuing operations (in thousands)
 
$
(2,736
)
Loss per share - continuing operations
 
$
(0.09
)
Weighted average number of common shares outstanding - basic and diluted
   
29,347,318
 

No adjustments have been made in the pro forma information for synergies that are resulting or planned from the MGI acquisition.  The unaudited proforma information is not indicative of the results that may have been achieved had the companies been combined as of January 1, 2018, or of our future operating results.

NOTE 5. CASH AND CASH EQUIVALENTS

As of March 31, 2020, we have $4.0 million of cash and cash equivalents invested in a money market fund with net assets invested in U.S. Dollar denominated money market securities of domestic and foreign issuers, U.S. Government securities and repurchase agreements.  We consider all liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents.

We have cash on deposit in excess of federally insured limits at a bank.  We do not believe that maintaining substantially all such assets with the bank or investing in a liquid mutual fund represent material risks.

NOTE 6. ACCOUNTS RECEIVABLE AND REVENUES

Amounts billed and due from our customers are classified as accounts receivables on our consolidated balance sheets and require payment on a short-term basis. Invoices are generally issued at the point control transfers and substantially all of our invoices are due within 30 days or less, however certain customers have terms of up to 120 days.  For substantially all of our contracts, control of the ordered product(s) transfers at our location.  Periodically, we require payment prior to the point in time we recognize revenue.  Amounts received from customers prior to revenue recognition on a contract are contract liabilities, are classified as customer prepayments liability on our consolidated balance sheets and are typically applied to an invoice within 30 days of the prepayment.  Revenues in the three months ended March 31, 2020, include less than $0.1 million in unearned revenue as of December 31, 2019.

RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

Our accounts receivable potentially subject us to significant concentrations of credit risk.  Revenues and accounts receivable from significant customers (customers with revenue or accounts receivable in excess of 10% of consolidated totals) are stated below as a percent of consolidated totals.

   
Customer
 
      A

    B

    C

    D

% of revenue, three months ended March 31, 2020
   
8
%
   
17
%
   
8
%
   
2
%
% of revenue, three months ended March 31, 2019
   
10
%
   
18
%
   
10
%
   
-
%
                                 
% of accounts receivable, as of March 31, 2020
   
9
%
   
25
%
   
13
%
   
4
%
% of accounts receivable, as of December 31, 2019
   
10
%
   
31
%
   
-
%
   
10
%

In all periods presented, less than 10% of our revenues related to shipments to locations outside of the U.S.  The following table presents revenues by product line (in thousands).

   
Three Months Ended March 31,
 
   
2020
   
2019
 
Food
 
$
6,192
   
$
4,747
 
Animal nutrition
   
2,138
     
1,617
 
Revenues
 
$
8,330
   
$
6,364
 

NOTE 7. INVENTORIES

The following table details the components of inventories (in thousands).

   
March 31,
2020
   
December 31,
2019
 
Finished goods
 
$
1,763
   
$
698
 
Raw materials
   
20
     
90
 
Packaging
   
133
     
110
 
Inventories
 
$
1,916
   
$
898
 

NOTE 8. LEASES

The components of lease expense and cash flows from leases (amounts in thousands) follow.

   
Three Months Ended March 31,
 
   
2020
   
2019
 
Finance lease cost:
           
Amortization of right-of use assets, included in cost of goods sold
 
$
21
   
$
4
 
Interest on lease liabilities
   
4
     
2
 
Operating lease cost, included in selling, general and administrative expenses:
               
Fixed leases cost
   
130
     
130
 
Variable lease cost
   
15
     
32
 
Short-term lease cost
   
3
     
9
 
Total lease cost
 
$
173
   
$
177
 
                 
Cash paid for amounts included in the measurement of lease liabilities:
               
Operating cash flows from finance leases
 
$
4
   
$
2
 
Operating cash flows from operating leases
 
$
130
   
$
130
 
Financing cash flows from finance leases
 
$
26
   
$
11
 

As of March 31, 2020, variable lease payments do not depend on a rate or index.  As of March 31, 2020, property and equipment, net, includes $0.3 million of finance lease right-of-use-assets, with an original cost of $0.4 million.

RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

As of March 31, 2020, we do not believe it is certain that we will exercise any renewal options.  The remaining terms of our leases and the discount rates used in the calculation of the fair value of our leases as of March 31, 2020, follows.

   
Operating
Leases
   
Finance
Leases
 
Remaining leases terms (in years)
   
3.6-12.9
     
0.8-4.3
 
Weighted average remaining lease terms (in years)
   
7.5
     
3.1
 
Discount rates
   
6.3%-9.0
%
   
4.3%-6.0
%
Weighted average discount rate
   
7.6
%
   
5.8
%

Maturities of lease liabilities as of March 31, 2020, follows (in thousands).

   
Operating
Leases
   
Finance
Leases
 
2020 (nine months ended December 31, 2020)
   
346
     
85
 
2021
   
536
     
91
 
2022
   
548
     
68
 
2023
   
528
     
38
 
2024
   
428
     
11
 
Thereafter
   
1,469
     
-
 
Total lease payments
   
3,855
     
293
 
Amounts representing interest
   
(996
)
   
(27
)
Present value of lease obligations
 
$
2,859
   
$
266
 

NOTE 9. DEBT

In the three months ended March 31, 2020, we financed amounts owed for annual insurance premiums under financing agreements, due in monthly installments of principal and interest though November 2020, at interest rates of 4.7% to 5.5% per year.

In October 2019, we entered into a factoring agreement which provides for a $7.0 million credit facility with a lender.  We may only borrow to the extent we have qualifying accounts receivable as defined in the agreement.  The facility has an initial two-year term and automatically renews for successive annual periods, unless proper termination notice is given.  We paid a $0.2 million facility fee upon inception of the agreement which is amortizing to interest expense on a straight-line basis over two years.  We incur recurring fees under the agreement, including a funding fee of 0.5% above the prime rate, in no event to be less than 5.5%, on any advances and a service fee on average net funds borrowed.  During the three months ended March 31, 2020, we expensed $0.1 million of interest and fees under the agreement, fees incurred averaged 3.9% (exclusive of deferred cost amortization) and interest averaged 1.7% of the amounts outstanding under the facility.  During the three months ended March 31, 2020, outstanding borrowings under the agreement averaged $1.1 million per day.  Amortization of debt issuance costs in the three months ended March 31, 2020, was less than $0.1 million.  The lender has the right to demand repayment of the advances at any time.  The lender has a security interest in personal property assets.

Due under factoring agreement consists of the following (in thousands).

   
March 31,
2020
   
December 31,
2019
 
Borrowings outstanding
 
$
2,449
   
$
1,989
 
Debt issuance costs, net
   
(143
)
   
(166
)
Due under factoring agreement
 
$
2,306
   
$
1,823
 

RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

Long-term debt consists of the following (in thousands).

   
March 31,
2020
   
December 31,
2019
 

           
Equipment notes - Initially recorded in November 2018, in the acquisition of Golden Ridge, at the present value of future payments using a discount rate of 4.8%, which we determined approximated the market rate for similar debt with similar maturities as of the date of acquisition.  Payable in monthly installments.
           
Expire at dates ranging through 2022.
 
$
56
   
$
62
 
Equipment note - Dated December 2019.  Due in monthly installments through December 2024.
               
Interest accrues at the effective discount rate of 9.3%.
   
38
     
39
 
Total long term debt
 
$
94
   
$
101
 

NOTE 10. EQUITY, SHARE-BASED COMPENSATION AND WARRANTS

A summary of equity activity for the three months ended March 31, 2020 and March 31, 2019, follows (in thousands, except share amounts).

   
Shares
                         
   
Preferred
Series G
   
Common
   
Preferred
Stock
   
Common
Stock
   
Accumulated
Deficit
   
Equity
 
Balance, December 31, 2019
   
225
     
40,074,483
   
$
112
   
$
318,811
   
$
(287,180
)
 
$
31,743
 
Common stock awards under equity incentive plans
   
-
     
17,534
     
-
     
312
     
-
     
312
 
Net loss
   
-
     
-
     
-
     
-
     
(3,033
)
   
(3,033
)
Balance, March 31, 2020
   
225
     
40,092,017
   
$
112
   
$
319,123
   
$
(290,213
)
 
$
29,022
 

   
Shares
                         
   
Preferred
Series G
   
Common
   
Preferred
Stock
   
Common
Stock
   
Accumulated
Deficit
   
Equity
 
Balance, December 31, 2018
   
405
     
29,098,207
   
$
201
   
$
296,739
   
$
(273,229
)
 
$
23,711
 
Proceeds from sale of common stock and prefunded warrant, net of costs
   
-
     
3,046,668
     
-
     
11,593
     
-
     
11,593
 
Common stock awards under equity incentive plans
   
-
     
36,881
     
-
     
364
     
-
     
364
 
Exercise of common stock warrants
   
-
     
600,000
     
-
     
1,980
     
-
     
1,980
 
Conversion of preferred stock into common stock
   
(180
)
   
170,818
     
(89
)
   
89
     
-
     
-
 
Exercise of common stock options
   
-
     
77,078
     
-
     
60
     
-
     
60
 
Other
   
-
     
-
     
-
     
28
     
-
     
28
 
Net loss
   
-
     
-
     
-
     
-
     
(3,227
)
   
(3,227
)
Balance, March 31, 2019
   
225
     
33,029,652
   
$
112
   
$
310,853
   
$
(276,456
)
 
$
34,509
 

On March 30, 2020, we entered into an at market issuance sales agreement with respect to an at-the-market offering program, under which we may offer and sell shares of our common stock having an aggregate offering price of up to $6.0 million through B. Riley FBR, Inc, as sales agent.  The issuance and sale, if any, of our common stock under the agreement will be made pursuant to our effective “shelf” registration statement on Form S-3.  We have deferred $0.1 million of legal expenses and other costs related to the offering which are included in other current assets in our consolidated balance sheets.

Share-based compensation by type of award for the three months ended March 31, 2020, follows (in thousands).

Common stock, vested at issuance and nonvested at issuance
 
$
105
 
Stock options
   
85
 
Restricted stock units
   
122
 
Compensation expense related to common stock awards issued under equity incentive plan
 
$
312
 

10

RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

In the three months ended March 31, 2020, we issued 17,534 shares of common stock, vested at issuance, to a consultant at a grant date fair value of $1.11 per share and recognized $0.1 million of expense for shares of common stock vesting during the period.

Stock options granted in the three months ended March 31, 2020, each vest and become exercisable in annual installments ending four years from the date of grant and were valued using methods and assumptions comparable to those for our 2019 stock option grants.  Stock option activity for the three months ended March 31, 2020, follows.

   
Shares
Under
Options
   
Weighted
Average
Exercise
Price
   
Weighted
Average
Grant
Date Fair
Value
   
Weighted
Average
Remaining
Contractual
Life (Years)
 
Outstanding at December 31, 2019
   
996,009
   
$
3.23
           
8.1
 
Granted
   
653,004
     
1.22
   
$
0.73
     
10.0
 
Forfeited
   
(125,173
)
   
4.74
             
7.2
 
Outstanding at December 31
   
1,523,840
   
$
2.24
             
8.8
 

Restricted stock unit (RSU) activity for the three months ended March 31, 2020, follows.

   
RSU Shares
Issued to
Employees
   
Unrecognized
Stock
Compensation
(in thousands)
   
Weighted
Average
Expense
Period (Years)
 
Nonvested at December 31, 2019
   
1,148,062
   
$
377
     
1.4
 
Cancelled
   
(625,000
)
   
-
         
Forfeited (1)
   
(175,000
)
   
(142
)
       
Expensed (2)
   
-
     
(122
)
       
Nonvested at March 31, 2020 (3)
   
348,062
   
$
113
     
1.2
 


(1)
We reversed $0.1 million of expense recognized prior to January 1, 2020 on forfeited RSU shares.

(2)
We expensed $0.1 million related to recognition of the unrecognized compensation associated with the cancelled RSU shares.

(3)
The shares subject to the RSUs vest based upon a vesting price equal to the volume weighted average trading price of our common stock over sixty-five consecutive trading days.  Subject to a minimum service period, as described in the next sentence, the RSU shares vest as to (i) 34,806 shares on the date the vesting price equals or exceeds $5.00 per share (ii) 104,419 shares the date the vesting price equals or exceeds $10.00 per share and (iii) 208,837 shares the date the vesting price equals or exceeds $15.00 per share.  Vesting on the RSU shares occurs the later of the one-year anniversary of the grant and the date the shares reach the vesting price indicated in the preceding sentence.  The RSUs expire on the fifth anniversary of each grant at dates ranging through August 2024.

In the three months ended March 31, 2020, warrants for the purchase of up to 265,000 shares of common stock ($5.25 per share exercise price) expired.

NOTE 11. INCOME TAXES

Our tax expense for the three months ended March 31, 2020 and 2019, differs from the tax expense computed by applying the U.S. statutory tax rate to net loss from continuing operations before income taxes as no tax benefits were recorded for tax losses generated in the U.S.  As of March 31, 2020, we had deferred tax assets primarily related to U.S. federal and state tax loss carryforwards.  We provided a full valuation allowance against our deferred tax assets as future realization of such assets is not more likely than not to occur.

Based on an analysis of tax positions taken on income tax returns filed, we have determined no material liabilities related to uncertain income tax positions exist.  Although we believe the amounts reflected in our tax returns substantially comply with applicable U.S. federal, state, and foreign tax regulations, the respective taxing authorities may take contrary positions based on their interpretation of the law.  A tax position successfully challenged by a taxing authority could result in an adjustment to our provision or benefit for income taxes in the period in which a final determination is made.

11

RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (CARES) was signed into law in the U.S.  The act, among other things, includes provisions relating to refundable payroll tax credits, deferment of employer social security payments, net operating loss carryback periods, alternative minimum tax credit refunds and modifications to the net interest deduction limitations. Some of these tax provisions are expected to be effective retroactively for years ending before the date of enactment. Except for the impact of the loan we received under the act, see Note 18, we do not anticipate that the act will have a material impact on our financial position, results of operations or cash flows.

NOTE 12. DISCONTINUED OPERATIONS

In July 2017, we completed the sale of the assets of Healthy Natural (HN).  The selling price was subject to adjustment if the estimated closing working capital with respect to the assets sold and the liabilities assumed was different than the actual closing working capital for those assets and liabilities.  The calculation of working capital was disputed.  The net gain on sale recognized in 2017 was based on an estimated working capital adjustment.  During the three months ended March 31, 2019, the estimated working capital adjustment increased from $0.3 million to $0.5 million when we finalized the adjustment with the purchaser of HN.  The adjustment to lower the gain on the sale of HN as a result of the change in the estimated working capital adjustment is recorded in discontinued operations in the three months ended March 31, 2019, net of zero tax benefit.

NOTE 13. LOSS PER SHARE (EPS)

Basic EPS is calculated under the two-class method under which all earnings (distributed and undistributed) are allocated to each class of common stock and participating securities based on their respective rights to receive dividends.  Our outstanding convertible preferred stock are considered participating securities as the holders may participate in undistributed earnings with holders of common shares and are not obligated to share in our net losses.

Diluted EPS is computed by dividing the net income attributable to RiceBran Technologies common shareholders by the weighted average number of common shares outstanding during the period increased by the number of additional common shares that would have been outstanding if the impact of assumed exercises and conversions is dilutive.  The dilutive effects of outstanding options, warrants, nonvested shares and restricted stock units that vest solely on the basis of a service condition are calculated using the treasury stock method.  The dilutive effects of the outstanding preferred stock are calculated using the if-converted method.

Below are reconciliations of the numerators and denominators in the EPS computations.

   
Three Months Ended March 31
 
   
2020
   
2019
 
NUMERATOR (in thousands):
           
Basic and diluted - loss from continuing operations
 
$
(3,033
)
 
$
(3,011
)
                 
DENOMINATOR:
               
Basic EPS - weighted average number of common shares outstanding
   
39,963,155
     
29,347,318
 
Effect of dilutive securities outstanding
   
-
     
-
 
Diluted EPS - weighted average number of shares outstanding
   
39,963,155
     
29,347,318
 
                 
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive:
               
Stock options
   
1,240,460
     
1,061,926
 
Warrants
   
406,695
     
10,020,616
 
Convertible preferred stock
   
213,523
     
259,075
 
                 
Weighted average number of shares of common stock issuable upon vesting of restricted stock units
   
1,035,425
     
1,215,000
 
                 
Weighted average number of nonvested shares of common stock not included in diluted EPS because effect would be antidilutive
   
116,528
     
1,044,709
 

12

RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

The impacts of potentially dilutive securities outstanding at March 31, 2020 and 2019, were not included in the calculation of diluted EPS for the three months ended March 31, 2020 and 2019 because to do so would be anti-dilutive.  Those securities listed in the table above which remain outstanding, could potentially dilute EPS in the future.

NOTE 14. FAIR VALUE MEASUREMENTS

The fair value of cash and cash equivalents, restricted cash, accounts and other receivables and accounts payable approximates their carrying value due to shorter maturities.  As of March 31, 2020, the fair values of our debt, operating lease liabilities and finance lease liabilities approximated their carrying values, based on current market rates for similar debt and leases with similar maturities (Level 3 measurements).

NOTE 15. COMMITMENTS AND CONTINGENCIES

Employment Contracts and Severance Payments

In the normal course of business, we periodically enter into employment agreements which incorporate indemnification provisions.  While the maximum amount to which we may be exposed under such agreements cannot be reasonably estimated, we maintain insurance coverage, which we believe will effectively mitigate our obligations under these indemnification provisions.  No amounts have been recorded in our financial statements with respect to any obligations under such agreements.

We have employment contracts with certain officers and key management that include provisions for potential severance payments in the event of without-cause terminations or terminations under certain circumstances after a change in control. In addition, vesting of outstanding nonvested equity grants would accelerate following a change in control.

Legal Matters

From time to time we are involved in litigation incidental to the conduct of our business.  These matters may relate to employment and labor claims, patent and intellectual property claims, claims of alleged non-compliance with contract provisions and claims related to alleged violations of laws and regulations.  When applicable, we record accruals for contingencies when it is probable that a liability will be incurred and the amount of loss can be reasonably estimated.  While the outcome of lawsuits and other proceedings against us cannot be predicted with certainty, in the opinion of management, individually or in the aggregate, no such lawsuits are expected to have a material effect on our financial position or results of operations.  Defense costs are expensed as incurred and are included in professional fees.

NOTE 16. RELATED PARTY TRANSACTIONS

Our director, Ari Gendason, is an employee and senior vice president and chief investment officer of Continental Grain Company (CGC).  As of the date of this filing, CGC owns approximately 26.6% of our outstanding common stock.  We have agreed that in connection with each annual or special meeting of our shareholders at which members of our board of directors are to be elected, or any written consent of our shareholders pursuant to which members of the board of directors are to be elected, CGC shall have the right to designate one nominee to our board of directors.  In March 2019, we issued and sold to CGC 666,667 shares of common stock at a purchase price of $3.00 per share and a prefunded warrant exercisable into 1,003,344 shares of common stock for $2.99 per share, in a private placement.  The prefunded warrant had an exercise price of $0.01 per share and was immediately exercisable; however, we had to obtain approval from our shareholders before the holder could exercise the prefunded warrant to the extent such exercise would result in the holder owning in excess of 19.99% of our common shares outstanding.  The holder exercised the entire prefunded warrant automatically when our shareholders approved the exercise in June 2019.

NOTE 17.  TRANSACTIONS WITH EMPLOYEES

During the three months ended March 31, 2019, we paid $1.4 million to entities owned by our former employee, Wayne Wilkison.  As of March 31, 2020, and December 31, 2019, no amounts were owed to these entities.

13

RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

NOTE 18.  SUBSEQUENT EVENTS

In April 2020, we were approved for a $1.8 million SBA Payroll Protection Program loan as provided for in CARES.  Under certain conditions, the loan and accrued interest are forgivable after eight weeks as long as we use the loan proceeds for eligible purposes, including payroll, benefits, rent and utilities, and maintains payroll levels. The amount of loan forgiveness will be reduced if we terminate employees or reduce salaries during the eight-week period.  The unforgiven portion of the loan is payable over two years at an interest rate of 1%, with a deferral of payments for the first six months.  We intend to use the proceeds for purposes consistent with the program.  While we currently believe that our use of the loan proceeds will meet the conditions for forgiveness of the loan, we cannot assure that we will be eligible for forgiveness of the loan, in whole or in part.

14

Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations

Results of Operations

Unless otherwise noted, amounts and percentages for all periods discussed below reflect the results of operations and financial condition from our continuing operations.

Revenues increased $2.0 million, or 31%, in the first quarter of 2020 compared to the first quarter of 2019.  The increase in revenue year-over-year was due to higher revenues from Golden Ridge Rice Mills (Golden Ridge) and MGI Grain Incorporated (MGI).  MGI was acquired in April 2019 and, therefore, our revenues included no MGI revenue in the first quarter of 2019.  By type, animal feed product revenues increased 32%, while food product revenues increased 30% year-over-year, primarily due to higher sales of finished rice from Golden Ridge and increased buying from our existing customer base.

We experienced a gross loss of $0.4 million in the first quarter of 2020, compared to a gross profit of $0.3 million in the first quarter of 2019.  The decline in gross profit was primarily attributable to higher losses from Golden Ridge due to sub-par milling yields in the first part of the first quarter of 2020, and an unfavorable spread on certain contracts which were delayed in fulfillment due to holdups in completing our debottlenecking project in the prior quarter.  This decline was offset in part by a higher gross profit from our core SRB operations due to favorable trends in product mix as well as deferred operating costs in inventory as we grow our inventory base for this business.

Selling, general and administrative (SG&A) expenses were $2.6 million in the first quarter of 2020, compared to $3.3 million in the first quarter of 2019, a decrease of $0.8 million.  The decline in SG&A expense was primarily related to the absence of approximately $0.3 million in costs associated with our acquisition of Golden Ridge in the comparable period a year ago, lower legal and outside accounting fees, as well the initial benefits from initiatives to reduce overall SG&A costs.

Other expense increased $0.1 million in the first quarter of 2020 compared to the first quarter of 2019.  This increase was primarily due to higher interest expense on the outstanding balance of our factoring facility, a new facility entered in to in the fourth quarter of 2019.

COVID-19 Assessment

The United States is experiencing an outbreak of a novel coronavirus (COVID-19), which has been declared a "pandemic" by the World Health Organization.  The COVID-19 pandemic has become a worldwide health crisis that is adversely affecting the economies and financial markets of many countries, which we expect may adversely affect the supply of the raw materials we use and the demand for the products we produce.  This pandemic also poses the risk that we, or our customers, suppliers and other business partners, may be disrupted or prevented from conducting business activities for certain periods of time, the durations of which are uncertain, and that we could see volatility in the price of the raw materials we use, or the demand for the products we produce. The extent of the impact of COVID-19 on our business and financial results will depend on future developments, including the duration and spread of the outbreak within the markets in which we operate, which is highly uncertain. As such, we are currently not able to estimate the exact magnitude of the impact of such developments on our business.

In April, we applied for, and received, a $1.8 million SBA Paycheck Protection Program loan as discussed further in Note 18 of the Notes to Unaudited Condensed Consolidated Financial Statements.  The funds from this loan will enable us to maintain our current workforce during any economic disruptions to our business as a result of the COVID-19 outbreak.  We currently do not expect any of our facilities to be subject to government-mandated closures as a result of the COVID-19 outbreak, and we have informed our customers that at this time we anticipate operating throughout the COVID-19 outbreak.  To date, the COVID-19 outbreak has not yet caused any material disruption in the supply of raw materials used in our products or in the distribution of our products, and our employees have been reporting to work, either remotely or in-person, without any material changes in attendance or productivity.

15

Liquidity and Capital Resources

We used $3.3 million in operating cash during the 2020 first quarter.  We used $1.0 million of operating cash in the first quarter of 2020 to increase our inventories in anticipation of a seasonal shut down of our Louisiana facilities in the second quarter.  We also had a $1.3 million increase in accounts receivable associated with growth in revenues at Golden Ridge.  These two items were partially offset by a $1.1 million increase in commodities payable due to the timing of associated sourcing contracts for Golden Ridge.  We funded $0.2 million of capital expenditures in the first quarter of 2020, and we expect this amount to increase in subsequent quarters as improved weather permits certain projects to be completed at Golden Ridge and MGI.  We funded our working capital needs in the first quarter of 2020, primarily with (i) a reduction in our cash reserves, (ii) net borrowings on our factoring facility, and (iii) by entering into a finance agreement for our annual insurance premiums.

On March 30, 2020, we entered into an at market issuance sales agreement with respect to an at-the-market offering program, under which we may offer and sell shares of our common stock having an aggregate offering price of up to $6.0 million.  In April 2020, we were approved for a $1.8 million SBA Payroll Protection Program loan as discussed further in Note 18 of the Notes to Unaudited Condensed Consolidated Financial Statements.  Management believes the COVID-19 outbreak had created general market uncertainty, which may currently limit the company’s ability to seek external sources of funding for investment initiatives and/or general operations.  However, with the $1.8 million in funds provided by the SBA Payment Protection Program loan, as of the date of this filing, management believes we have sufficient capital reserves and borrowing capacity to maintain our workforce and fund the operations of the business through the remainder of our current fiscal year.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements, other than employee contracts, that have or are likely to have a current or future material effect on our financial condition, changes in financial condition, revenue, expenses, results of operations, liquidity, capital expenditures, or capital resources.

Critical Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based upon unaudited condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America.  The preparation of financial statements requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, revenues and expenses and disclosures on the date of the financial statements.  On an ongoing basis, we evaluate the estimates, including, but not limited to, those related to revenue recognition.  We use authoritative pronouncements, historical experience and other assumptions as the basis for making judgments.  Actual results could differ from those estimates.

Recent Accounting Pronouncements

See Note 3 in the Notes to Unaudited Condensed Consolidated Financial Statements for further discussion.

Item 3.
Quantitative and Qualitative Disclosures about Market Risk

Not applicable

16

Item 4.
Controls and Procedures 

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required financial disclosures.

We evaluated, with the participation of our chief executive officer, and chief financial officer, the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q.  Based on this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.

Changes in Internal Control over Financial Reporting

During the most recently completed fiscal quarter, there have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1.
Legal Proceedings

We are involved in or subject to, or may become involved in or subject to, routine litigation, claims, disputes, proceedings and investigations in the ordinary course of business.  While the outcome of lawsuits and other proceedings against us cannot be predicted with certainty, in the opinion of management, individually or in the aggregate, no such lawsuits are expected to have a material effect on our financial position, results of operations or cash flows.  We record accruals for contingencies when it is probable that a liability will be incurred and the amount of loss can be reasonably estimated.

Item 1A.
Risk Factors

In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019, which could materially affect our business, financial condition, liquidity or future results.  The risks described in our Annual Report on Form 10-K are not the only risks facing our company.  Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, liquidity or future results.

Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds

None

Item 3.
Defaults upon Senior Securities

None

Item 4.
Mine Safety Disclosures

None

Item 5.
Other Information

None

Item 6.
Exhibits

17

The following exhibits are attached hereto and filed herewith:

       
Incorporated by Reference
   
Exhibit
Number
 
Exhibit Description
 
Form
 
File No.
 
Exhibit
Number
 
Filing/Effective
Date
 
Filed
Here-
with
 
At Market Issuance Sales Agreement with B Riley FBR, Inc.
 
8-K
 
001-36245
 
10.1
 
March 30, 2020
   
 
Employment Agreement with Todd T. Mitchell dated May 28, 2019
 




 
May 16, 2019
 
X
 
Certification by CEO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
                 
X
 
Certification by CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
                 
X
 
Certification by CEO and CFO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
                 
X
101.INS (1)
 
XBRL Instance Document
                 
X
101.SCH (1)
 
XBRL Taxonomy Extension Schema Document
                 
X
101.CAL (1)
 
XBRL Taxonomy Extension Calculation Linkbase Document
                 
X
101.DEF (1)
 
XBRL Taxonomy Extension Calculation Definition Linkbase Document
                 
X
101.LAB (1)
 
XBRL Taxonomy Extension Calculation Label Linkbase Document
                 
X
101.PRE (1)
 
XBRL Taxonomy Extension Calculation Presentation Linkbase Document
                 
X


(1)
XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

(2)
Indicates a management contract or compensatory plan, contract or arrangement.

18

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated:  May 5, 2020
   
     
 
/s/ Brent R. Rystrom
 
 
Brent R. Rystrom
 
 
Director and Chief Executive Officer

 
/s/ Todd T. Mitchell
 
 
Todd T. Mitchell
 
 
Chief Financial Officer


19


EXHIBIT 10.2
 
EMPLOYMENT AGREEMENT

This Employment Agreement ("Agreement") is entered into on May 28, 2019 ("Effective Date"), by and between RiceBran Technologies, a California corporation ("RBT"), and Todd T. Mitchell, an individual ("Employee"). The parties hereto agree as follows:
 
1.          Employment. RBT hereby employs Employee and Employee hereby accepts employment with RBT on the terms and conditions set forth herein.

2.           Employment; Scope of Employment. Employee shall be employed as Executive Vice- President as of the Effective Date and as of June 1, 2019 shall be the Executive Vice-President and Chief Financial Officer of RBT. Employee shall report to RBT's Chief Executive Officer and the Chairman of the Audit Committee ("Audit Committee") of RBT's Board of Directors ("Board"). RBT reserves the exclusive right to designate and modify Employee's specific duties from time to time in any manner consistent with Employee's status as Executive Vice-President and Chief Financial Officer. No modification or change of Employee's responsibilities and/or duties shall modify, change or revoke any provision of this Agreement.
 
2.1      Best Efforts; Full Working Time. Employee shall devote substantially all of Employee's business time, attention, skill and experience and shall apply Employee's best efforts to the performance of Employee's duties and the business and affairs of RBT.  Employee may engage in charitable activities and community affairs, and manage Employee's personal investments and affairs, so long as such activities do not, either individually or in the aggregate, materially interfere with the proper performance of Employee's duties and responsibilities hereunder.

2.2     Supervision and Direction of Services. All of Employee's services shall be under the supervision and direction of the Chief Executive Officer of RBT and the Chairman of the Audit Committee.

2.3     Rules. Employee shall be bound by all the policies, rules, regulations, plans, programs, agreements and arrangements of RBT now in force, and by all such other policies, rules, regulations, plans, programs, agreements and arrangements as may be hereafter implemented (collectively, "Company Arrangements") and shall faithfully observe and abide by the same. No such policy, rule or regulation shall alter, modify or revoke the provisions of this Agreement, including RBT's right to terminate Employee's employment at any time, with or without cause.
 
2.4      Exclusive Services. During the Term, Employee shall not, directly or indirectly, whether as a partner, employee, creditor, shareholder, independent contractor or otherwise, promote, participate or engage in any activity or other business that is competitive with RBT's business operations; provided, however, that this provision shall not preclude or prohibit Employee from holding or obtaining an indirect and passive beneficial ownership, through a mutual fund or similar arrangement, of up to one percent of any publicly-held company which is competitive with RBT as long as he does not otherwise promote, participate or engage in the business operations of such company. Employee agrees that Employee shall not enter into an agreement to establish, form, contract with or become employed by a competing business of RBT while Employee is employed by RBT.
 

2.5      Non-Solicitation. To the fullest extent permissible under applicable law, Employee agrees that both during the Term and for a period of two (2) years following termination of this Agreement, Employee shall not take any action to induce employees or independent contractors, or customers, suppliers or vendors of RBT to sever their relationship with RBT and accept an employment or an independent contractor relationship, or any other applicable relationship with any other business.

2.6      Office Location. Employee shall primarily perform Employee's duties under this Agreement at RBT's principal offices, but shall provide services at such other locations as the Chief Executive Officer or the Board may designate from time-to-time.
 
3.           Term and Termination; Payments upon Termination.

3.1     Term and Termination. Unless earlier terminated as described below, RBT hereby employs the Employee under this Agreement for a period commencing on the Effective Date and ending on December 31, 2019 (the "Term"). The period commencing on the Effective Date and ending on December 31, 2019, and each succeeding twelve (12) month period during the Term, are each referred to herein as a "Contract Year." The Term shall be extended automatically for successive one-year terms unless either party notifies the other party in writing at least ninety (90) days prior to the expiration of the then-effective Term of such party's intention not to renew this Agreement.
 
3.1.1      Termination for Cause. No termination of Employee's employment hereunder for Cause shall be effective unless RBT shall first have given written notice to Employee  (the "Cause Notice") of its intention to terminate Employee for Cause, such Cause Notice shall state the circumstances that constitute the grounds on which the termination for Cause is based. "Cause" for termination of Employee's employment shall mean the occurrence of any of the following:
 
(a)          Employee breaches a material term of this Agreement, which breach remains uncured for thirty (30) days after delivery of the Cause Notice (which Cause Notice shall describe the breach in sufficient detail to allow Employee the reasonable opportunity to cure the breach, if susceptible of being cured within such thirty (30) day period);
 
(b)       Employee has been grossly negligent or engaged in material willful or gross misconduct in the performance of Employee's duties;
 
(c)        Employee has committed, as reasonably determined by the Board, or has been convicted by a court of law of fraud, moral turpitude, embezzlement, theft, or similar criminal conduct, or any felony;
 
(d)          Employee's habitual misuse of alcohol, drugs, or any controlled substance; or


(e)       Employee's (i) breach of the Proprietary Information Agreement (as defined below) or (ii) failure to comply with reasonable written standards established by RBT for the performance of Employee's duties hereunder.
 
3.1.2       Termination for Good Reason.
 
(a)         Employee may terminate this Agreement for Good Reason, as defined herein, subject to and provided that Employee complies with the requirements of Section 3.l .2(b). As used herein, "Good Reason" means (i) any material breach by RBT of any provision of this Agreement (other than a reduction of Employee's Base Salary as part of a general reduction of the salaries of all of RBT's executive officer employees); (ii) a material reduction of Employee's duties or responsibilities (or the assignment of duties or responsibilities to Employee that are) not consistent or commensurate with Employee's position as Chief Executive Officer, but not including any reduction in Employee's duties during any investigation or proceedings initiated by RBT pursuant to Section 3.1.1 with regard to a possible termination of Employee for Cause; or (iii) any reduction of Employee's Base Salary other than as part of a general reduction of the salaries of all of RBT's executive officer employees.
 
(b)         In order to terminate this Agreement for Good Reason, Employee shall provide RBT with (i) written notice of the Good Reason (which notice must be delivered within ninety (90) days following the date Employee first learns of the occurrence of the event constituting Good Reason and which notice shall describe the particulars of RBT's breach in sufficient detail to allow RBT reasonable opportunity to remedy or eliminate the Good Reason(s), if susceptible of being remedied or eliminated); and (ii) thirty (30) days within which to remedy or eliminate the Good Reason(s). In the event that Employee provides such notice and RBT fails to remedy or eliminate the Good Reason(s) within such 30-day period, Employee shall be entitled to provide RBT with written notice (of not less than fifteen (15) days) that Employee is terminating this Agreement as a result of such Good Reason(s) (such notice, a "Good Reason Resignation Notice"). In order for Employee's termination of this Agreement to be for Good Reason, (i) the Good Reason Resignation Notice must be delivered to RBT within twenty (20) days after the end of such 30-day period in which RBT was unable to remedy or eliminate the Good Reason(s) and (ii) the Good Reason Resignation Notice must set forth the effective date of Employee's termination, which termination date must not be less than fifteen (15) days after the date that Employee delivered the Good Reason Resignation Notice to the Company.
 
3.1.3    Voluntary Termination of Employment. Employee agrees (a) to provide at least ninety (90) days prior written notice (a "Voluntary Termination Notice") of Employee's intention to voluntarily terminate Employee's employment with RBT for any reason other than Good Reason, death or Disability (as defined below) (a "Voluntary Termination") and (b) to specify in such notice a fixed date for the Voluntary Termination. A termination of this Agreement by reason of Employee's non-renewal shall be deemed to be a Voluntary Termination.

3.2      Payments upon Termination.
 
3.2.1       For Cause, Volunatry Termination, or Disability. If RBT terminates Employee's employment for Cause, or if Employee terminates by Voluntary Termination, or if either party terminates this Agreement due to Employee's Disability, Employee shall be entitled to receive in a cash lump sum payment (less normal and customary deductions and withholdings) an amount equal to all accrued but unpaid compensation (including accrued but unused vacation leave) as of the date of such termination (such payment shall be made within the time period required by applicable law, but in no event later than thirty (30) days following the date of termination).
 

3.2.2       Without Cause, for Good Reason, or Death.

(a)         In the event Employee's employment is terminated (i) by RBT other than for Cause, (ii) by Employee for Good Reason, or (iii) due to Employee's death, Employee (or Employee's estate or legal representative) shall be entitled to a cash lump sum payment an amount equal to (1) all previously accrued but unpaid compensation (including accrued but unused vacation leave) as of the date of such termination and (2) the Base Salary that Employee would  have been paid had he remained employed with RBT for the ninety (90) day period beginning  immediately after RBT gives notice to Employee of Employee's termination (or beginning immediately after Employee provides RBT with the Good Reason Resignation Notice). Employee's right to the payments due under this Section 3.2.2(a}(2} are conditioned upon and shall be payable no later than ten (10) days following the effective date of Employee's execution and delivery to RBT of a general release of form and content reasonably acceptable to RBT.
 
(b)         For purposes of this Agreement, "Disability" shall mean that Employee, due to a physical or mental disability, has been substantially unable to perform Employee's duties under this Agreement for a continuous period of ninety (90) days or longer, or for one hundred and twenty (120) days or more in any twelve (12) month period.
 
3.2.3     Section 409A. Notwithstanding any provision of this Agreement to the contrary, if Employee is a "specified employee" as defined in Section 409A of the Internal Revenue Code of 1986, as amended (the "Code"), he shall not be entitled to any payments upon a termination of Employee's employment under any arrangement that constitutes "nonqualified deferred compensation" under Section 409A until the earlier of (i) the date which is six (6) months after Employee's separation from service (as such term is defined in Section 409A of the Code and the regulations and other published guidance hereunder) for any reason other than death, or (ii) the date of Employee's death. After the date of termination, Employee shall have no duties or responsibilities that are inconsistent with having a separation from service as of such date. Any amounts otherwise payable to Employee following a termination of employment that are not so paid by reason of this Section 3.2.3 shall be paid promptly following, and in any event within fifteen (15) days following, the date that is six (6) months after Employee's separation from service (or, if  earlier, the date of Employee's death).

3.2.4       Termination upon a Change of Control. Within sixty (60) days prior to or ninety (90) days after the effective date of a Change of Control (as defined below), either RBT or Employee may, upon thirty (30) days' prior written notice to the other, terminate Employee's employment. In the event of any such termination of Employee's employment (and regardless of whether such termination occurs with or without such thirty (30) day notice), RBT shall pay to Employee (a) the severance and other benefits set forth in Section 3.2.2, and (b) an additional severance payment of an amount equal to the Base Salary that Employee would have been paid had he remained employed with RBT for the one hundred and eighty (180) day period beginning immediately after such termination, but Employee shall be entitled to such additional severance payment under this part (b) only if Employee executes and delivers to RBT a general release of form and content reasonably acceptable to RBT. Such payment shall be payable in accordance with applicable law, but in no event later than thirty (30) days following the date of termination (and Employee's execution and delivery of a general release, in the case of payments to be made under Section 3.2.2(a)(2), if applicable, or part (b) of this Section 3.2.4). For the purposes of this Agreement, the term "Change of Control" shall mean any of the following events: (x) the consummation of a merger or consolidation of RBT with any other entity which results in the voting securities of RBT outstanding immediately prior thereto failing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than fifty percent (50%) of the total voting power represented by the voting securities of RBT or such surviving entity outstanding immediately after such merger or consolidation, or (y) the sale or other transfer in one or more transactions not in the ordinary course of RBT's business or personal property assets constituting more than fifty percent (50%) of the personal property assets of RBT and its subsidiaries (taken as a whole) to any such person or group of persons; provided, however, that the sale of the assets or equity interests of any RBT subsidiary shall not constitute a Change of Control.
 

4.        Compensation; Benefits.

4.1        Base Salary. Employee shall be paid at a rate which, on an annualized basis, equals two hundred thirty-five thousand dollars ($235,000) per year, as adjusted pursuant to this Section 4.1 ("Base Salary"). The Base Salary shall be subject to normal payroll withholdings and RBT's standard payroll practices. For each Contract Year after the initial Contract Year, Employee's Base Salary shall be subject to increase as determined by the Board in its discretion.

4.2        Annual Bonus Program. Employee shall participate in the RBT Management Incentive Program and any other annual bonus program that is generally applicable to senior officers of RBT (subject to the terms and conditions of such program). Any such annual bonus program must be approved by the RBT Compensation Committee and shall set forth objective criteria for bonus payments based on the financial performance of RBT. Such annual bonus program also shall set forth a target bonus objectives and metrics for Employee, which shall be set by the Board in its sole discretion. Employee shall be eligible for an annual bonus of up to forty-five percent (45%) of Employee's Base Salary subject to the achievement of such target bonus performance objectives in accordance with the terms of the program. The actual annual bonus amount, if any, shall be paid in accordance with the terms of such program and may be paid in cash or stock incentives or a combination of cash and stock incentives.

4.3          Equity Incentive Awards. As of the Effective Date, RBT shall grant Employee an option ("Option") to acquire seventy-five thousand (75,000) shares of the Company's Common Stock pursuant to the terms of the RBT 2014 Omnibus Incentive Plan ("Plan") and the associated the Option Agreement dated as of the Effective Date. The Option will vest over a four year period commencing on the first date of your employment twenty-five percent (25%) vesting on the one year anniversary of your employment and the balance vesting on an equal monthly basis, one thirty-sixth (1/36) each month, over the remaining thirty-six (36) months. Employee must comply with the terms of the Plan and remain employed by the Company in order to accrue and vest rights to exercise the Option. RBT also shall grant Employee one-hundred and twenty-five thousand (125,000) restricted stock units ("RSU's") pursuant to the terms of the Plan and associated grant agreement. Employee shall be entitled to receive additional equity incentive awards at the discretion of the Board or its Compensation Committee. Any grant of an additional equity incentive award shall require the approval of the Board or its Compensation Committee and be subject to the terms and conditions of the corresponding grant agreements, incentive programs and equity incentive plans.
 

4.4         Vacation and other Standard Benefits. Employee shall be entitled to four (4) weeks of paid vacation time per year. Employee may not accrue vacation time in excess of such four (4) weeks maximum. Accrual of vacation time shall be subject to the terms and conditions of RBT's vacation policy. Employee shall be entitled to health benefits in accordance with RBT's standard policies. In addition, Employee is entitled to paid holidays, sick leave and other benefits m accordance with RBT's standard policies.
 
4.5       Business Expenses. Employee shall be reimbursed for reasonable business expenses which he incurs in the performance of Employee's duties hereunder, in accordance with RBT's standard reimbursement policies.
 
4.6        Relocation Expenses. RBT shall reimburse Employee for the documented and reasonable expenses incurred by Employee in moving his primary residence to Texas, but not including the costs of selling his current family home or purchasing a new home, up to an aggregate maximum often thousand dollars ($10,000).

4.7         Inconsistencies. In the event of any inconsistency between any provision of this Agreement and any provision of any Company Arrangement, the provisions of this Agreement shall control.

5.         Employee's Representations. Employee represents and warrants to RBT that information provided by Employee about Employee to RBT in connection with Employee's employment and any supplemental information provided to RBT is, to the best of Employee's knowledge and information after good faith diligence and investigation, complete, true and correct. Employee has not omitted any information that is necessary to evaluate the information provided by Employee to RBT. Employee shall promptly notify RBT of any change in the accuracy or completeness of all such information.
 
6.          Trade Secrets. Employee acknowledges that RBT has expended substantial time and expense to develop customers and to develop procedures and processes for development of products and services and the sales of products and services. Such procedures and processes in addition to various other types of proprietary information are included as part of the "confidential information" described in the "Proprietary Information Agreement" between RBT and Employee and attached hereto as Exhihit A. RBT and Employee agree that the Proprietary Information Agreement attached hereto as Exhibit A continues to be in full force and effect. Nothing in this Agreement alters the obligations of Employee under the Proprietary Information Agreement.
 
7.           Remedies for Breach of Covenant Regarding Confidentiality. The parties agree that the breach by Employee of any covenants contained in Sections 2.4, 2.5, and 6 will result in immediate and irreparable injury to RBT. In the event of any breach by Employee of the covenants contained in Sections 2.4, 2.5, or 6, RBT shall be entitled to seek recourse through all available legal and equitable remedies necessary or useful to prevent any likelihood  of immediate or irreparable injury to RBT. The parties agree that, in the case of such a breach or threat of breach by Employee of any  of the provisions of such Sections, RBT may take any appropriate legal action, including without limitation action for injunctive relief, consisting of orders temporarily restraining and preliminarily and permanently enjoining such actual or threatened breach.
 

8.           Miscellaneous.
 
8.1      Choice of Law. The rights and obligations of the parties and the interpretation and performance of this Agreement shall be governed by the laws of Texas, excluding its conflict oflaws rules, except as such laws may be interpreted, enforced, or preempted by federal law.

8.2.    Entire Agreement. This Agreement and the Proprietary Information Agreement contain the entire agreement among the parties hereto with respect to the subject matter hereof, and supersede all prior and contemporaneous oral and written agreements, understandings and representations among the parties. There are no representations, agreements, arrangements, or understandings, whether oral or written, between or among the parties relating to the subject matter of this Agreement that are not fully expressed herein and therein. This Agreement amends and restates the Prior Employment Agreement in its entirety as of the Effective Date.

8.3     Notices. Any notice under this Agreement shall be in writing, and any written notice or other document shall be deemed to have been duly given (i) on the date of personal service on the parties, (ii) on the third business day after mailing, if the document is mailed by registered  or certified mail, (iii) one day after being sent by professional or overnight courier or messenger service guaranteeing one-day delivery, with receipt confirmed by the courier, or (iv) on the date of transmission if sent by telegram, telex, telecopy or other means of electronic transmission  resulting in written copies, with receipt confirmed. Any such notice shall be delivered or addressed to the parties at the addresses set forth on the signature page below or at the most recent address specified by the addressee through written notice under this provision. Failure to conform to the requirement that mailings be done by registered or certified mail shall not defeat the effectiveness of notice actually received by the addressee.
 
8.4     Severability. RBT and Employee agree that should any provision of this Agreement be declared or be determined by any court or other tribunal (including an arbitrator) of competent jurisdiction to be illegal, invalid or unenforceable, the legality, validity and enforceability of the remaining parts, terms and provisions shall not be affected thereby, and said illegal, unenforceable or invalid part, term or provision shall be deemed not to be part of this Agreement.
 
8.5      Amendment. The provisions of this Agreement may be modified at any time by agreement of the parties; provided that such modification shall be ineffective unless in writing and signed by the parties hereto.
 
8.6    No Transfer or Assignment; No Third-Party Beneficiaries. The rights of Employee hereunder have been granted by RBT with the understanding that this Agreement is personal to, and shall be performed by Employee individually. This Agreement is not transferable or assignable by Employee in any manner. No person or entity other than RBT and Employee shall have any rights whatsoever under this Agreement. No person or entity other than RBT or Employee shall have any right to enforce any provision of this Agreement, or to recover damages on account of the breach of this Agreement. No heir, successor or assign of Employee, whether voluntarily or by operation of law, shall have or succeed to any rights ofRBT or Employee hereunder.
 

8.7      Waiver. Any of the terms or conditions of this Agreement may be waived at any time by the party entitled to the benefit thereof, but no such waiver shall affect or impair the right of the waiving party to require observance, performance or satisfaction of that term or condition as it applies on a subsequent occasion or of any other term or condition.
 
8.8      Resolution of Disputes.

8.8.1      Resolution of Disputes. RBT and Employee agree that, except as otherwise provided herein, any claim or controversy arising out of or pertaining to this Agreement or the termination of Employee's employment, including but not limited to, claims of wrongful  treatment or termination allegedly resulting from discrimination, harassment or retaliation on the basis of race, sex, age, national origin, ancestry, color, religion, marital status, status as a veteran of the Vietnam era, physical or mental disability, medical condition, or any other basis prohibited by  law ("Dispute") shall be resolved by binding arbitration as provided in this Section 8.8.
 
8.8.2       Binding Arbitration. The provisions of this Section 8.8 shall not preclude any party from seeking injunctive or other provisional or equitable relief in order to preserve the status quo of the parties pending resolution of a Dispute, and the filing of an action seeking injunctive or other provisional relief shall not be construed as a waiver of that party's arbitration rights. Except as provided herein, the arbitration of any Dispute between the parties to this Agreement shall be governed by the American Arbitration Association ("AAA") Commercial Arbitration Rules (the "AAA Rules").
 
8.8.3      Appointment of Arbitrator. Within thirty (30) days of service of a demand for arbitration by either party to this Agreement, the parties shall endeavor in good faith to select from the AAA list of labor and employment arbitrators a single arbitrator, who must be a licensed attorney; if the parties fail to do so within such thirty (30) day period, an arbitrator shall be selected in accordance with the AAA Rules.
 
8.8.4      Initiation of Arbitration. In the case of any Dispute between the parties to this Agreement, either party shall have the right to initiate the binding arbitration process provided for in this paragraph by serving upon the other party a demand for arbitration within the statutory time period from the date the Dispute first arose.
 
8.8.5       Location of Arbitration. Any arbitration hearing shall be conducted m Houston, Texas.
 
8.8.6     Applicable Law. The law applicable to the arbitration of any Dispute shall be, as provided in Section 8.1 and the Federal Arbitrator Act (Title 9, U.S. Code, Section 1 et Seq.).


8.8.7      Arbitration Procedures. In addition to any of the procedures or processes available under the AAA Rules, the parties shall be entitled to conduct discovery sufficient to adequately arbitrate their claims and/or defenses, including access to relevant documents and witnesses, as determined by the arbitrator(s). In addition, either party may choose, at that party's discretion, to request that the arbitrator(s) resolve any dispositive motions prior to the taking of evidence on the merits of the Dispute. In the event a party to the arbitration requests that the arbitrator(s) resolve a dispositive motion, the arbitrator(s) shall receive and consider any written or oral arguments regarding the dispositive motion, and shall receive and consider any evidence specifically relating thereto, and shall render a decision thereon, before hearing any evidence on the merits of the Dispute.

8.8.8     Scope of Arbitrators' Award or Decision. RBT  and  Employee  agree that if the arbitrator(s) find any Disputed claim to be meritorious, the arbitrator(s) shall have the authority  to order all forms of legal and/or equitable relief that would otherwise be available in court and that is appropriate to the claim. Any decision or award by the arbitrator(s) shall be a reasoned opinion in writing citing facts and law and shall be specific enough to permit limited judicial review if necessary.

8.8.9     Costs of Arbitration; Attorneys' Fees. RBT and Employee agree that the arbitrator(s), in their discretion and consistent with applicable law, may award to the prevailing party the costs incurred by that party in participating in the arbitration process as long as they do not exceed those that would be incurred by Employee in a court action.
 
8.8.10   Acknowledgment of Consent to Arbitration. NOTICE: BY EXECUTING THIS AGREEMENT THE PARTIES AGREE TO HAVE ANY DISPUTE ARISING OUT OF THE MATTERS INCLUDED IN THE "RESOLUTION OF DISPUTES" PROVISION DECIDED BY NEUTRAL ARBITRATION AS PROVIDED HEREIN AND WAIVE ANY RIGHTS THEY MAY HAVE TO HAVE THE DISPUTE DECIDED BY A JUDGE OR A JURY.  BY EXECUTING THIS AGREEMENT, THE PARTIES WAIVE THEIR JUDICIAL RIGHTS TO APPEAL. IF EITHER PARTY REFUSES TO SUBMIT TO ARBITRATION AFTER AGREEING TO THIS PROVISION, SUCH PARTY MAY BE COMPELLED TO ARBITRATE. THE PARTIES' AGREEMENT TO THIS ARBITRATION PROVISION IS VOLUNTARY. THE PARTIES REPRESENT THAT THEY HAVE READ AND UNDERSTAND THE FOREGOING AND AGREE TO SUBMIT DISPUTES ARISING OUT OF THE MATTERS INCLUDED IN THIS PROVISION TO NEUTRAL ARBITRATION.
 
8.10    Exhibits. All exhibits to which reference is made are deemed incorporated in this Agreement whether or not actually attached.
 
[Signature Page Follows]


The parties hereto have executed and delivered this Employment Agreement as of the Effective Date set forth above.

RBT:
 
EMPLOYEE:
 
 
 
 
RICEBRAN TECHNOLOGIES,
 
 
 
a California corporation
 
 
 
 
 
 
 
 
/s/ Brent R. Rystrom
  /s/ Todd T. Mitchell  
By: Brent R. Rystrom  
By:
Todd T. Mitchell
Title: Chief Executive Officer  
 
 
 
 
 
 
Address:   
Address:
        
1330 Lake Robbins Drive, Suite 250        
The Woodlands, Texas 977380        




Exhibit 31.1

Certification of Principal Executive Officer
 Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Brent R. Rystrom, certify that:

1)
I have reviewed this quarterly report on Form 10-Q of RiceBran Technologies;

2)
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3)
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4)
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report was prepared;


b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5)
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):


a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s disclosure internal control over financial reporting.

Dated:  May 5, 2020
 /s/ Brent R. Rystrom
 
     
 
Name: Brent R. Rystrom
 
Title: Director and Chief Executive Officer




Exhibit 31.2

Certification of Principal Financial Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Todd T. Mitchell, certify that:

1)
I have reviewed this quarterly report on Form 10-Q of RiceBran Technologies;

2)
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3)
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4)
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report was prepared;


b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5)
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):


a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s disclosure internal control over financial reporting.

Dated:  May 5, 2020
/s/ Todd T. Mitchell
 
 
 
 
Name: Todd T. Mitchell
 
Title: Chief Financial Officer





Exhibit 32.1

Certification of Principal Executive Officer and Principal Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of RiceBran Technologies (the Company) for the period ended March 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the Report), each of the undersigned, in the capacities and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Company.

Dated:  May 5, 2020
   
     
 
/s/ Brent R. Rystrom
 
 
Brent R. Rystrom
 
 
Director and Chief Executive Officer

 
/s/ Todd T. Mitchell
 
 
Todd T. Mitchell
 
 
Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

The foregoing certification is being furnished in accordance with Securities and Exchange Commission Release No. 34-47551 and shall not be considered filed as part of the Form 10-Q.